Nimodipine

규격

66085-59-4CAS 번호

266-127-0EC 번호

3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylateIUPAC 명칭

C21H26N2O7화학식

418.4 g/mol분자량

nimodipine; 66085-59-4; Nimotop; Periplum; Admon; Nimodipino; Nymalize; Nimodipinum; BAY e 9736; Bay-e-9736; nemotan; Nimodipine ap; DTXSID5023370; Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester; 57WA9QZ5WH; NSC-758476; CHEBI:7575; 3-(2-methoxyethyl) 5-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; DTXCID003370; 3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate; Nimodipin ISIS; 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester; Hexal, Nimodipin; Bayvit, Nimodipino; O5-(2-methoxyethyl) O3-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; nimodipina; e 9736, Bay; RefChem:56660; C08CA06; 266-127-0; Nimodipinum [INN-Latin]; Nimodipino [INN-Spanish]; Bay-E 9736; 3-isopropyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; MFCD00153848; C21H26N2O7; MLS000863294; s1747; 2-methoxyethyl propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; NCGC00015714-09; SMR000058300; M02160; O5-isopropyl O3-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; NimoGel; DRG-0139; Nimotop(TM); 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methyloxyethyl 1-methylethyl ester; SR-01000075335; NIMOTOP (TN); EINECS 266-127-0; UNII-57WA9QZ5WH; BRN 0459792; Nimodipin; NimoVent; Kenesil;; Nimotop;; Nimodipine CRS; Calnit;; Admon;; Nimodipine, API; Nimodipine [USAN:USP:INN:BAN]; Nymalize (TN); CAS-66085-59-4; Nimodipine (Nimotop); EG-1961; Nimodipine (Standard); Opera_ID_14; Spectrum_001880; NIMODIPINE [MI]; SpecPlus_000716; Nimodipine (USP/INN); NIMODIPINE [INN]; NIMODIPINE [JAN]; Prestwick0_000918; Prestwick1_000918; Prestwick2_000918; Prestwick3_000918; Spectrum2_001562; Spectrum3_000766; Spectrum4_000791; Spectrum5_001687; NIMODIPINE [USAN]; N-149; NIMODIPINE [VANDF]; NIMODIPINE [MART.]; NIMODIPINE [USP-RS]; NIMODIPINE [WHO-DD]; (+/-)-NIMODIPINE; CBiol_001832; Lopac0_000891; SCHEMBL34041; BSPBio_000796; BSPBio_001397; BSPBio_002412; KBioGR_000117; KBioGR_001262; KBioSS_000117; KBioSS_002408; MLS000069381; MLS001076550; MLS001424155; MLS002154061; MLS002172461; MLS003899190; DivK1c_006812; SPECTRUM1503600; SPBio_001464; SPBio_002985; BPBio1_000876; GTPL2523; orb1224312; orb1310704; orb3139926; CHEMBL3197349; NIMODIPINE [ORANGE BOOK]; SCHEMBL22882841; SCHEMBL29382758; HY-B0265R; KBio1_001756; KBio2_000117; KBio2_002403; KBio2_002685; KBio2_004971; KBio2_005253; KBio2_007539; KBio3_000233; KBio3_000234; KBio3_001632; BRD8407; NIMODIPINE [EP MONOGRAPH]; NIMODIPINE [USP IMPURITY]; Bio1_000118; Bio1_000607; Bio1_001096; Bio2_000117; Bio2_000597; HMS1361F19; HMS1570H18; HMS1791F19; HMS1922E04; HMS1989F19; HMS2052M05; HMS2089H13; HMS2093G11; HMS2097H18; HMS2234B05; HMS3262D04; HMS3266O22; HMS3369G07; HMS3394M05; HMS3402F19; HMS3411I12; HMS3657I03; HMS3675I12; HMS3714H18; HMS5079J22; NIMODIPINE [USP MONOGRAPH]; Pharmakon1600-01503600; 3,5-pyridinecarboxylic acid 2-methoxyethyl 1-methylethyl ester; ALBB-015317; BRD-8407; HY-B0265; MSK10220; Tox21_110202; Tox21_500891; BBL028286; BDBM50101971; CA-211; CCG-39340; EBC-11180; NSC758476; STK642934; AKOS005174934; AKOS015852459; Tox21_110202_1; AC-8484; CCG-101085; DB00393; II57946; KS-1304; LP00891; NC00335; NSC 758476; SDCCGSBI-0050866.P004; 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide; IDI1_033867; isopropyl 2-methoxyethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; NCGC00015714-04; NCGC00015714-05; NCGC00015714-06; NCGC00015714-07; NCGC00015714-08; NCGC00015714-10; NCGC00015714-11; NCGC00015714-12; NCGC00015714-13; NCGC00015714-16; NCGC00015714-28; NCGC00021456-02; NCGC00024675-02; NCGC00024675-03; NCGC00024675-04; NCGC00024675-05; NCGC00024675-06; NCGC00024675-07; NCGC00024675-08; NCGC00024675-09; NCGC00261576-01; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl 1-methylethyl ester; 1-methylethyl 2-(methyloxy)ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; Nimodipine 100 microg/mL in Acetonitrile; PD003072; PD033038; SMR002530605; ST082783; SY076731; SBI-0050866.P003; AB00513963; EU-0100891; N0896; N3448; NS00006836; SW219238-1; T0343; C07267; D00438; EN300-123527; F20554; SBI-0050866.0001; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-; AB00053314-03; AB00053314-04; AB00053314_05; AB00053314_06; F570790; Q421429; SR-01000075335-1; SR-01000075335-2; SR-01000075335-4; SR-01000075335-5; SR-01000075335-7; BRD-A58048407-001-06-3; BRD-A58048407-001-09-7; BRD-A58048407-001-17-0; BRD-A58048407-001-18-8; BRD-A58048407-001-20-4; Z53829207; Nimodipine, British Pharmacopoeia (BP) Reference Standard; Nimodipine, European Pharmacopoeia (EP) Reference Standard; Nimodipine, United States Pharmacopeia (USP) Reference Standard; Nimodipine, Pharmaceutical Secondary Standard; Certified Reference Material; Nimodipine for peak identification, EuropePharmacopoeia (EP) Reference Standard; (RS)-Iso-propyl-2-methoxyethyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate; 2-Methoxyethyl 1-Methylethyl 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate; 3,5-PYRIDINEDICARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-, 3-(2-METHOXYETHYL) 5-(1-METHYLETHYL) ESTER; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,?2-methoxyethyl 1-methylethyl ester; 3-Isopropyl 5-(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate #; 3-isopropyl5-(2-methoxyethyl)2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate; isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate; methylethyl 5-[(2-methoxyethyl)oxycarbonyl]-2,6-dimethyl-4-(3-nitrophenyl)-1,4 -dihydropyridine-3-carboxylate동의어